Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001209191-22-002245

Options or other derivatives

  • President acquired 53,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dubensky Thomas W. President 2022-01-04 Grant or award · Stock Option (Right to Buy) +53,100 53,100 D
Loading xslF345X03/doc4.xml…